Public advisory - One lot of ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% mild lotion recalled due to an impurity that may pose health risks [Yahoo! Finance]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
Issue: Health products – Product quality What to do: Do not use this product. Consult a health care professional if you have used this product and have health concerns. Return products to your local pharmacy for proper disposal Affected products Product DIN Lot Expiry ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% mild lotion, 60 mL Issue Teva Canada Ltd. is recalling one lot of ratio-ECTOSONE (TEVA-ECTOSONE) 0.05% mild lotion in 60 mL bottles. This action follows testing that detected an impurity—betamethasone enol aldehyde—above the accepted limit in the affected lot. This impurity can form due to a chemical change in the drug during storage and may pose health risks, including the possibility of adverse reactions on the skin or elsewhere in the body from being absorbed into the bloodstream . The risk may be greater in children who may absorb proportionally larger amounts of the impurity and be more susceptible to adverse reactions. The product is a prescription corticost
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Real-World Evidence and Life Science Analytics 2 Day Conference (Boston, USA - October 17th-18th 2024) - Shaping the Future of Healthcare [Yahoo! Finance]Yahoo! Finance
- Medincell to Present Data Showing Enhanced Potential of Tumor-Targeting Monoclonal Antibody in Melanoma Using BEPO® Technology [Yahoo! Finance]Yahoo! Finance
- Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex [Yahoo! Finance]Yahoo! Finance
- New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses [Yahoo! Finance]Yahoo! Finance
- New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment PausesBusiness Wire
TEVA
Earnings
- 5/8/24 - Miss
TEVA
Sec Filings
- 6/25/24 - Form 8-K
- 6/21/24 - Form 4
- 6/18/24 - Form 144
- TEVA's page on the SEC website